{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:30:46Z","timestamp":1788582646734,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gene"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.gene.2012.06.013","type":"journal-article","created":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T04:58:41Z","timestamp":1339995521000},"page":"266-268","source":"Crossref","is-referenced-by-count":54,"title":["X-inactivation in Fabry disease"],"prefix":"10.1016","volume":"505","author":[{"given":"Deborah","family":"Elstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Schachamorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Beeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gheona","family":"Altarescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.gene.2012.06.013_bb0005","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/GIM.0b013e31820ad795","article-title":"Natural history of Danon disease","volume":"13","author":"Boucek","year":"2011","journal-title":"Genet. Med."},{"issue":"15","key":"10.1016\/j.gene.2012.06.013_bb0010","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood-2008-12-195677","article-title":"Skewing of X-inactivation ratios in blood cells of aging women is confirmed by independent methodologies","volume":"113","author":"Busque","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.gene.2012.06.013_bb0085","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ajmg.a.33770","article-title":"Are MPS II heterozygotes actually asymptomatic? A study based on clinical and biochemical data, X-inactivation analysis and imaging evaluations","volume":"155A","author":"de Camargo Pinto","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"issue":"4","key":"10.1016\/j.gene.2012.06.013_bb0090","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/jmg.2005.036327","article-title":"Natural history of Fabry disease in females in the Fabry Outcome Survey","volume":"43","author":"Deegan","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.gene.2012.06.013_bb0025","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.gene.2012.06.013_bb0095","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00109-005-0656-2","article-title":"Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population","volume":"83","author":"Dobrovolny","year":"2005","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.gene.2012.06.013_bb0100","series-title":"Fabry Disease: Perspectives from 5 Years of FOS","article-title":"Epidemiology of lysosomal storage diseases: an overview","author":"Fuller","year":"2006"},{"issue":"451","key":"10.1016\/j.gene.2012.06.013_bb0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/08035320600618809","article-title":"Disease manifestations and X inactivation in heterozygous females with Fabry disease","volume":"95","author":"Maier","year":"2006","journal-title":"Acta Paediatr. Suppl."},{"issue":"Suppl. 1","key":"10.1016\/j.gene.2012.06.013_bb0045","first-page":"S66","article-title":"Anderson-Fabry disease: developments in diagnosis and treatment","volume":"47","author":"Mehta","year":"2009","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.gene.2012.06.013_bb0050","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1111\/j.1749-6632.2010.05943.x","article-title":"Genetics and epigenetics of the X chromosome","volume":"1214","author":"Morey","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.gene.2012.06.013_bb0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1750-1172-5-14","article-title":"Expression of the disease on female carriers of X-linked lysosomal disorders: a brief review","volume":"5","author":"Pinto","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.gene.2012.06.013_bb0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2215\/CJN.08091109","article-title":"Assessment of renal pathology and dysfunction in children with Fabry disease","volume":"5","author":"Ramaswami","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.gene.2012.06.013_bb0065","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bbadis.2010.05.003","article-title":"Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease","volume":"1802","author":"Rombach","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.gene.2012.06.013_bb0105","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/jhg.2011.31","article-title":"Fabry-database.org: database of the clinical phenotypes, genotypes and mutant \u03b1-galactosidase A structures in Fabry disease","volume":"56","author":"Saito","year":"2011","journal-title":"J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.gene.2012.06.013_bb0110","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00428-008-0653-2","article-title":"Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy","volume":"453","author":"Valbuena","year":"2008","journal-title":"Virchows Arch."},{"key":"10.1016\/j.gene.2012.06.013_bb0080","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-0004.2004.00219.x","article-title":"The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy","volume":"6","author":"Whybra","year":"2004","journal-title":"Clin. Genet."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111912007068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111912007068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T18:54:23Z","timestamp":1542912863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111912007068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0378111912007068"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2012.06.013","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}